MidWestOne Financial Group’s Ascendis Pharma A/S ASND Stock Holding History

MidWestOne Financial Group’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$654K	Buy	+3,067	New	+$633K	0.07%	196

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

MidWestOne Financial Group's ASND Position: Q4 2025 in Review

MidWestOne Financial Group opened a new position in Ascendis Pharma A/S (ASND) in Q4 2025: 3,067 shares worth $654K. The stake represents 0.07% of the portfolio and ranks #196 among its holdings.

302 funds tracked by Wall St. Rank hold ASND as of Q4 2025.

MidWestOne Financial Group held 3,067 shares of Ascendis Pharma A/S worth $654K as of Q4 2025.
Ascendis Pharma A/S was a new MidWestOne Financial Group position in Q4 2025.
Ascendis Pharma A/S made up 0.07% of MidWestOne Financial Group's portfolio in Q4 2025, its #196 holding.
302 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q4 2025.

Based on MidWestOne Financial Group's 13F filing for Q4 2025, filed 12 Feb 2026.